Pharming Group N.V. (PHGUF)
OTCMKTS · Delayed Price · Currency is USD
2.150
+0.300 (16.22%)
At close: Jan 27, 2026
Pharming Group Market Cap
Pharming Group has a market cap or net worth of $1.06 billion as of February 12, 2026. Its market cap has increased by 79.92% in one year.
Market Cap
1.06B
Enterprise Value
1.02B
Revenue
362.27M
Ranking
n/a
PE Ratio
2,766.89
Stock Price
$2.15
Market Cap Chart
Since June 16, 1999, Pharming Group's market cap has increased from 128.85M to 1.06B, an increase of 720.27%. That is a compound annual growth rate of 8.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 1.08B | -5.96% |
| Dec 31, 2025 | 1.15B | 76.58% |
| Dec 31, 2024 | 649.63M | -14.84% |
| Dec 29, 2023 | 762.86M | 0.93% |
| Dec 30, 2022 | 755.82M | 32.18% |
| Dec 31, 2021 | 571.80M | -42.41% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Northwest Biotherapeutics | 406.62M |
| CytoDyn | 317.38M |
| Silence Therapeutics | 224.36M |
| Vaxart | 145.67M |
| HST Global | 139.70M |
| BioStem Technologies | 104.83M |
| Nuo Therapeutics | 80.63M |
| VitaSpring Biomedical | 51.78M |